N6-methyladenosine-related lncRNAs is a potential marker for predicting prognosis and immunotherapy in ovarian cancer

IF 2.1 3区生物学 Q3 GENETICS & HEREDITY

Hereditas Pub Date : 2022-03-18 DOI:10.1186/s41065-022-00222-3

Xin Nie, Jichun Tan

引用次数: 3

查看原文本刊更多论文

n6 -甲基腺苷相关lncrna是预测卵巢癌预后和免疫治疗的潜在标志物

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Hereditas 生物-遗传学

CiteScore

4.30

自引率

3.70%

发文量

审稿时长

6 weeks

期刊介绍： For almost a century, Hereditas has published original cutting-edge research and reviews. As the Official journal of the Mendelian Society of Lund, the journal welcomes research from across all areas of genetics and genomics. Topics of interest include human and medical genetics, animal and plant genetics, microbial genetics, agriculture and bioinformatics.